Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

W Li, JB Liu, LK Hou, F Yu, J Zhang, W Wu, XM Tang… - Molecular cancer, 2022 - Springer
Primary lung cancer is one of the most common malignant tumors in China. Approximately
60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is …

Long-range gene regulation in hormone-dependent cancer

TT Tettey, L Rinaldi, GL Hager - Nature Reviews Cancer, 2023 - nature.com
The human genome is organized into multiple structural layers, ranging from chromosome
territories to progressively smaller substructures, such as topologically associating domains …

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

SG Zhao, M Bootsma, S Zhou, R Shrestha… - Nature …, 2024 - nature.com
The impact of variations in the three-dimensional structure of the genome has been
recognized, but solid cancer tissue studies are limited. Here, we performed integrated deep …

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer

R Vatapalli, V Sagar, Y Rodriguez, JC Zhao… - Nature …, 2020 - nature.com
The histone methyltransferase DOT1L methylates lysine 79 (K79) on histone H3 and is
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression

A Alpsoy, SM Utturkar, BC Carter, A Dhiman… - Cancer research, 2021 - AACR
Abstract Switch/sucrose-nonfermentable (SWI/SNF) chromatin-remodeling complexes are
critical regulators of chromatin dynamics during transcription, DNA replication, and DNA …

Identification of immune-related lncRNA prognostic signature and molecular subtypes for glioblastoma

W Yu, Y Ma, W Hou, F Wang, W Cheng, F Qiu… - Frontiers in …, 2021 - frontiersin.org
Background Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally
heterogeneous, which poses challenges for classification and management. Long …

[HTML][HTML] H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility

C Giambartolomei, JH Seo, T Schwarz… - The American Journal of …, 2021 - cell.com
Genome-wide association studies (GWASs) have identified more than 200 prostate cancer
(PrCa) risk regions, which provide potential insights into causal mechanisms. Multiple lines …

The genomic and epigenomic landscape of double-negative metastatic prostate cancer

A Lundberg, M Zhang, R Aggarwal, H Li, L Zhang… - Cancer Research, 2023 - AACR
Systemic targeted therapy in prostate cancer is primarily focused on ablating androgen
signaling. Androgen deprivation therapy and second-generation androgen receptor (AR) …

FOXA1 regulates alternative splicing in prostate cancer

M Del Giudice, JG Foster, S Peirone, A Rissone… - Cell Reports, 2022 - cell.com
Dysregulation of alternative splicing in prostate cancer is linked to transcriptional programs
activated by AR, ERG, FOXA1, and MYC. Here, we show that FOXA1 functions as the …

Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression

S Goel, V Bhatia, S Kundu, T Biswas… - Nature …, 2021 - nature.com
Abstract Distal-less homeobox-1 (DLX1) is a well-established non-invasive biomarker for
prostate cancer (PCa) diagnosis, however, its mechanistic underpinnings in disease …